The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration
Open accessAbstract
Background: Measuring systemic inflammatory markers may improve clinical prognosis and help identify targetable pathways for treatment in patients with autosomal dominant forms of frontotemporal lobar degeneration (FTLD). Methods: We measured plasma concentrations of IL-6, TNFα and YKL-40 in pathogenic variant carriers ( MAPT, C9orf72, GRN ) and non-carrier family members enrolled in the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration consortium. We evaluated associations between baseline plasma inflammation and rate of clinical and neuroimaging changes (linear mixed effects models with standardised (z) outcomes). We compared inflammation between asymptomatic carriers who remained clinically normal (‘asymptomatic non-converters’) and those who became symptomatic (‘asymptomatic converters’) using area under the curve analyses. Discrimination accuracy was compared with that of plasma neurofilament light chain (NfL). Results: We studied 394 participants (non-carriers=143, C9orf72 =117, GRN =62, MAPT =72). In MAPT , higher TNFα was associated with faster functional decline (B=0.12 (0.02, 0.22), p=0.02) and temporal lobe atrophy. In C9orf72, higher TNFα was associated with faster functional decline (B=0.09 (0.03, 0.16), p=0.006) and cognitive decline (B=−0.16 (−0.22, −0.10), p<0.001), while higher IL-6 was associated with faster functional decline (B=0.12 (0.03, 0.21), p=0.01). TNFα was higher in asymptomatic converters than non-converters (β=0.29 (0.09, 0.48), p=0.004) and improved discriminability compared with plasma NfL alone (ΔR 2 =0.16, p=0.007; NfL: OR=1.4 (1.03, 1.9), p=0.03; TNFα: OR=7.7 (1.7, 31.7), p=0.007). Conclusions: Systemic proinflammatory protein measurement, particularly TNFα, may improve clinical prognosis in autosomal dominant FTLD pathogenic variant carriers who are not yet exhibiting severe impairment. Integrating TNFα with markers of neuronal dysfunction like NfL could optimise detection of impending symptom conversion in asymptomatic pathogenic variant carriers and may help personalise therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Subsequent intensive research even suggested that plasma IL-6 and TNF-α levels may be positively correlated with the rate of cognitive decline.338”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [338]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W., & Smith, S. M. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.015 · Cited by 11,314
SMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citationAppelhof, B., Bakker, C., Van Duinen-van den Ijssel, J. C. L., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,760
Revision of the Self-Monitoring Scale.
Lennox, R. D., & Wolfe, R. N. (1984) · Journal of Personality and Social Psychology · doi:10.1037//0022-3514.46.6.1349 · Cited by 1,225 · cited 1×
“The familywise error correction was performed using 5000 permutations with threshold free cluster enhancement[19].”
MethodBang, J., Spina, S., & Miller, B. L. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00461-4 · Cited by 1,144
The heritability and genetics of frontotemporal lobar degeneration
Rohrer, J. D., Guerreiro, R., Vandrovcova, J., Uphill, J., Reiman, D., Beck, J., Isaacs, A. M., Authier, A., Ferrari, R., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf997a · Cited by 536
C9orf72 suppresses systemic and neural inflammation induced by gut bacteria
Burberry, A., Wells, M. F., Limone, F., Couto, A., Smith, K. S., Keaney, J., Gillet, G., van Gastel, N., Wang, J.-Y., Pietilainen, O., et al. (2020) · Nature · doi:10.1038/s41586-020-2288-7 · Cited by 314
TDP-43 activates microglia through NF-κB and NLRP3 inflammasome
Zhao, W., Beers, D. R., Bell, S., Wang, J., Wen, S., Baloh, R. H., & Appel, S. H. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.019 · Cited by 241
The Role of Immune and Inflammatory Mechanisms in ALS
A. McCombe, P., & D. Henderson, R. (2011) · Current Molecular Medicine · doi:10.2174/156652411795243450 · Cited by 232
Research works printed but not linked: 1
- 10.1037/0022-3514.46.6.1349 · DOI · Paper page
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Biomarker-guided decision making in clinical drug development for neurodegenerative disorders
Cummings, J. L., Teunissen, C. E., Fiske, B. K., Ber, I. L., Wildsmith, K. R., Schöll, M., Dunn, B., & Scheltens, P. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01165-w · Cited by 87
“…plus National Alzheimer’s Coordinating Center (CDR plus NACC FTLD) 129 and NfL levels provide prognostic information for clinical decline in patients with familial FTD 130 and may provide a means of identifying slow and fast progressors, particularly among those with the C9orf72 genotype 131 .”
Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration
Malpetti, M., Swann, P., Tsvetanov, K. A., Chouliaras, L., Strauss, A., Chikaura, T., Murley, A. G., Ashton, N. J., Barker, P. J., Jones, P. S., et al. (2024) · Brain · doi:10.1093/brain/awae269 · Cited by 52
“54 Elevated TNF-α levels were also previously observed in plasma of 129 patients with svPPA compared with neurologically healthy controls.”
Progranulin deficiency in the brain: the interplay between neuronal and non-neuronal cells
Gawęda-Walerych, K., Aragona, V., Lodato, S., Sitek, E. J., Narożańska, E., & Buratti, E. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00475-8 · Cited by 23
Tachibana, A., Iga, J., Ozaki, T., Yoshida, T., Yoshino, Y., Shimizu, H., Mori, T., Furuta, Y., Shibata, M., Ohara, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-57922-1 · Cited by 18
“Interestingly, plasma inflammation predicted phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration 49 .”
Background
Metadata
- Authors
- Asken, B. M., Ljubenkov, P. A., Staffaroni, A. M., Casaletto, K. B., Vandevrede, L., Cobigo, Y., Rojas-Rodriguez, J. C., Rankin, K. P., Kornak, J., Heuer, H., Shigenaga, J., Appleby, B. S., Bozoki, A. C., Domoto-Reilly, K., Ghoshal, N., Huey, E., Litvan, I., Masdeu, J. C., Mendez, M. F., Pascual, B., Pressman, P., Tartaglia, M. C., Kremers, W., Forsberg, L. K., Boeve, B. F., Boxer, A. L., Rosen, H. J., & Kramer, J. H.
- Affiliations
- University of California, San Francisco (US)
- San Francisco VA Medical Center (US)
- Case Western Reserve University (US)
- University of North Carolina at Chapel Hill (US)
- Washington University in St. Louis (US)
- Columbia University (US)
- University of California San Diego (US)
- Houston Methodist (US)
- University of California, Los Angeles (US)
- University of Colorado Anschutz (US)
- University of Toronto (CA)
- Mayo Clinic (US)
- Corresponding author
- Asken, Breton M
- ORCID
- Asken, Breton M
- Ljubenkov, Peter A
- Staffaroni, Adam M
- Casaletto, Kaitlin B
- Vandevrede, Lawren
- Cobigo, Yann
- Rankin, Katherine P
- Kornak, John
- Heuer, Hilary
- Appleby, Brian S
- Bozoki, Andrea C
- Ghoshal, Nupur
- Huey, Edward
- Litvan, Irene
- Masdeu, Joseph C
- Pressman, Peter
- Tartaglia, Maria Carmela
- Kremers, Walter
- Forsberg, Leah K
- Boxer, Adam L
- Kramer, Joel H
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2023-03-28
- Volume
- 94
- Issue
- 7
- Pages
- 541-549
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- PMC
- PMC10313977
- OpenAlex
- W4361020091
- Cited by
- 16
- References
- 41
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute on Aging and the National Institute of Neurological Diseases and Stroke (U01 AG045390, U19 AG063911)
- National Institute of Neurological Diseases and Stroke and National Center for Advancing Translational Sciences (U54 NS092089)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- systemic inflammation, TNF-α, interleukin-6, YKL-40, plasma neurofilament light chain, C9orf72, gene regulatory networks, MAPT, asymptomatic carriers, phenotypic conversion, clinical progression, functional decline, cognitive decline, temporal lobe atrophy, biomarkers, disease prediction, neuroinflammation
- MeSH terms
- C9orf72 Protein, Humans, Inflammation, Mutation, Tumor Necrosis Factor-alpha, Interleukin-6, tau Proteins, Disease Progression, Frontotemporal Lobar Degeneration, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration. https://app.cochat.ai/papers/10.1136/jnnp-2022-330866
- The paper
- Asken, B. M., Ljubenkov, P. A., Staffaroni, A. M., Casaletto, K. B., Vandevrede, L., Cobigo, Y., Rojas-Rodriguez, J. C., Rankin, K. P., Kornak, J., Heuer, H., Shigenaga, J., Appleby, B. S., Bozoki, A. C., Domoto-Reilly, K., Ghoshal, N., Huey, E., Litvan, I., Masdeu, J. C., Mendez, M. F., . . . Kramer, J. H. (2023). Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2022-330866
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.